Glucocorticoids reduce nitric oxide concentration in middle ear effusion from lipopolysaccharide induced otitis media

International Journal of Pediatric Otorhinolaryngology

Volumn 74, Issue 4, 2010, Pages 384-386

  Pudrith, Charles ^a   Martin, Dusan ^a   Kim, You Hyun ^a   Jahng, Patrick ^a   Kim, Biblia ^a   Wall, Michael ^b   Jung, Timothy ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALCON RESEARCH LTD   (United States)

Author keywords

Glucocorticoid; Nitric oxide; Otitis media with effusion

Indexed keywords

DEXAMETHASONE; FLUTICASONE PROPIONATE; GLUCOCORTICOID; LIPOPOLYSACCHARIDE; NITRIC OXIDE; RIMEXOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL PROLIFERATION; CHINCHILLA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; EAR PROTECTION; HAIR CELL; NONHUMAN; PERCEPTION DEAFNESS; PRIORITY JOURNAL; SECRETORY OTITIS MEDIA;

ANDROSTADIENES; ANIMALS; CHINCHILLA; DEXAMETHASONE; GLUCOCORTICOIDS; LIPOPOLYSACCHARIDES; NITRIC OXIDE; OTITIS MEDIA WITH EFFUSION; PREGNADIENES;

EID: 77549085356     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2010.01.008     Document Type: Article

References (21)

1. Rovers M.M. The burden of otitis media. Vaccine 23 26 (2008) Suppl. 7:G2-4
2. Ogura M., Furukawa M., Tada N., Ikeda H., and Yamashita T. Platelet-activating factor (PAF) induced cytokine production and otitis media with effusion (OME) in the rat middle ear. Auris Nasus Larynx 35 3 (2008) 338-343
3. Johnson M., Leonard G., and Kreutzer D.L. Murine model of interleukin-8-induced otitis media. Laryngoscope 107 10 (1997) 1405-1408
4. El Kebir D., Hubert B., Taha R., Troncy E., Wang T., Gauvin D., et al. Effects of inhaled nitric oxide on inflammation and apoptosis after cardiopulmonary bypass. Chest 128 4 (2005) 2910-2917
5. John E.O., Russell P.T., Nam B.H., Jinn T.H., and Jung T.T.K. Concentration of nitric oxide metabolites in middle ear effusion. Int. J. Pediatr. Otorhinolaryngol. 60 1 (2001) 55-58
6. Kasai K., Hattori Y., Nakanishi N., Manaka K., Banba N., Motohashi S., et al. Regulation of inducible nitric oxide production by cytokines in human thyrocytes in culture. Endocrinology 136 10 (1995) 4261-4270
7. Heinrich U.R., Fischer I., Brieger J., Rumelin A., Schmidtmann I., Math D., et al. Ascorbic acid reduces noise-induced nitric oxide production in the guinea pig ear. Laryngoscope 118 5 (2008) 837-842
8. Jung T.T., Llaurado R.J., Nam B.H., Park S.K., Kim P.D., and John E.O. Effects of nitric oxide on morphology of isolated cochlear outer hair cells: possible involvement in sensorineural hearing loss. Otol. Neurotol. 24 4 (2003) 682-685
9. Albina J.E., and Reichner J.S. Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis. Cancer Metastasis Rev. 17 1 (1998) 39-53
10. Liu H., Chi F., and Gao W. Taurine attenuates aminoglycoside ototoxicity by inhibiting inducible nitric oxide synthase expression in the cochlea. Neuroreport 19 1 (2008) 117-120
11. Rogatsky I., and Ivashkiv L.B. Glucocorticoid modulation of cytokine signaling. Tissue Antigens 68 1 (2006) 1-12
12. Dohar J., Giles W., Roland P., Bikhazi N., Carroll S., Moe R., et al. Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes. Pediatrics 118 3 (2006) e561-e569
13. Roland P.S., Waycaster C.R., Wall G.M., and Glass J.D. An economic evaluation of two ototopical treatments for acute otitis media in tympanostomy tube patients. Value Health 9 4 (2006) 219-226
14. Roland P.S., Kreisler L.S., Reese B., Anon, Lanier B., Conroy P.J., et al. Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. Pediatrics 113 1 Pt 1 (2004) e40-e46
15. Shinoda J., McLaughlin K.E., Bell H.S., Swaroop G.R., Yamguchi S.I., Holmes M.C., et al. Molecular mechanisms underlying dexamethasone inhibition of iNOS expression and activity in C6 glioma cells. Glia 42 1 (2003) 68-76
16. Hebda P.A., Burckar G.J., Alper C.M., Swarts J.D., Antonio S.M., Zeevi A., et al. Effect of 10 pharmacologic probes on mRNA levels of inducible nitric oxide synthetase and selected inflammatory cytokines in a rat model of acute otitis media. Acta Otolaryngol. 122 3 (2002) 255-261
17. Hanson J.B., Russell P.T., Chung A.T., Kaura C.S., Kaura S.H., John E.O., et al. Effect of round window membrane application of nitric oxide on hearing and nitric oxide concentration in perilymph. Int. J. Pediatr. Otorhinolaryngol. 67 6 (2003) 585-590
18. Jeon Y.J., Han S.H., Lee Y.W., Lee M., Yang K.H., and Kim H.M. Dexamethasone inhibits IL-1 beta gene expression in LPS-stimulated RAW 264.7 cells by blocking NF-kappa B/Rel and AP-1 activation. Immunopharmacology 48 2 (2000) 173-183
19. Juhn S.K., Jung M., Hoffman M.D., Drew B.R., Preciado D.A., Sausen N.J., et al. The role of inflammatory mediators in the pathogenesis of otitis media and sequelae. Clin. Exp. Otorhinolaryngol. 1 3 (2008) 117-138
20. Cope D., and Bova R. Steroids in otolaryngology. Laryngoscope 118 9 (2008) 1556-1560
21. Florea A., Zwart J.E., Lee C.W., Depew A., Park S.K., Inman J., et al. Effect of topical dexamethasone versus rimexolone on middle ear inflammation in experimental otitis media with effusion. Acta Otolaryngol. 126 9 (2006) 910-915